HMOX1 and obesity due to melanocortin 4 receptor deficiency: Upregulation of HO-1 expression in obesity and type 2 diabetes results in a decrease in visceral and subcutaneous fat content, improved insulin sensitivity, and increased insulin receptor phosphorylation [22, 69–71].